The neurotoxicant, trimethyltin (TMT) produces cochlear impairment at
far lower dose levels and far more rapidly than it does central nervou
s system effects. The initial effects of TMT in the cochlea, in vivo,
are consistent with disruption of the inner hair cell type-1 spiral ga
nglion cell synapse although it is uncertain whether the effect is on
presynaptic and/or postsynaptic units. This synapse is believed to be
an excitatory glutamatergic one, providing the possibility that TMT co
uld induce an excitotoxic process resulting in elevations in intracell
ular calcium ([Ca2+](i)). The objective of this study was to determine
whether TMT had direct toxic effects on the postsynaptic spiral gangl
ion cells studied in primary culture and to identify the role of extra
cellular calcium in such an effect. The marker of interest was the eff
ect of this agent on [Ca2+](i) levels as determined using quantitation
of the fluorescent calcium dye, Fura-2. TMT did induce a marked and s
ustained elevation in [Ca2+](i) level in the spiral ganglion cells tha
t appeared to have a rapid initial phase and a slower saturating phase
. Studies performed using calcium-free medium showed that elevation of
[Ca2+](i) in spiral ganglion cells by TMT was attenuated but not enti
rely blocked. Further, the L-type calcium channel blocker, nifedipine,
was able to inhibit the initial increase in [Ca2+](i), suggesting tha
t at least this phase of the TMT effect was mediated by calcium channe
ls, although nifedipine had no significant effect on the time to reach
the maximal [Ca2+](i) level. Parallel control experiments performed u
sing application of exogenous glutamate and depolarizing K+ concentrat
ions also produced elevation in [Ca2+](i) levels. The data indicate th
at TMT elevates [Ca2+](i) in isolated spiral ganglion cells both by in
creasing extracellular uptake via Ca2+ channels and also by releasing
Ca2+ from intracellular stores. Thus TMT ototoxicity appears to includ
e a direct postsynaptic toxic event.